by Editorial | Apr 27, 2020 | 2020 News, Bio World
San Diego-based Genalyte Inc. said its rapid COVID-19 serology panel is now available on its Maverick platform. The test detects IgG and IgM antibodies to the novel coronavirus, SARS-CoV-2. READ MORE
by Editorial | Apr 27, 2020 | 2020 News, SD Metro
Genalyte, a next-generation lab service company focused on decentralizing diagnostic testing, has acquired BaseHealth, a Bay Area health care data analytics company. The combined company will provide onsite, rapid diagnostics with data analytics capabilities to enable...
by Editorial | Apr 27, 2020 | 2020 News, RT Magazine
Genalyte has released its rapid SARS-CoV-2 Multi-Antigen Serology Panel, a COVID-19 diagnostic that can detect antibodies in patients who have had the virus. The diagnostic is run on Genalyte’s Maverick platform. The panel tests for the detection of IgG and...
by Editorial | Apr 27, 2020 | 2020 News
First Instrument-Based, Rapid Test Uses Multi-Antigen Approach to Achieve Best-in-Class Sensitivity and Specificity, U.S. FDA EUA Submitted SAN DIEGO, April 27, 2020 /PRNewswire/ — Genalyte, the company empowering physicians and patients with...
by Editorial | Apr 25, 2020 | 2020 News, 360DX
As labs and diagnostic developers race to meet demand for assays to detect the SARS-CoV-2 coronavirus, 360Dx is updating this tracker on a regular basis in order to provide readers with up-to-date and accurate information on the regulatory status of these tests in the...
Recent Comments